Pamplona Capital Management Completes Sale of MedAssets’ Spend and Clinical Resource Management Segment to Vizient
Pamplona Capital Management (Pamplona) is pleased to announce it has completed the sale of MedAssets’ Spend and Clinical Resource Management (SCM) segment to Vizient, Inc., the largest member-owned health care company in the country.
The sale marks the final step in Pamplona’s plan to combine MedAssets’ Revenue Cycle Management (RCM) segment with Precyse, a Pamplona-owned health information management (HIM) company, to create a leader in the end-to-end revenue cycle services, technology and education market.
“The completion of this sale was a critical piece in executing our vision for building a national leader in the end-to-end revenue cycle services, technology and education market,” said Jeremy Gelber, M.D., partner at Pamplona Capital Management. “We can now proceed with full integration of the combined MedAssets-Precyse enterprise, leveraging the strengths of each company to better meet the demands of our evolving reimbursement environment.”
In addition to the sale of the MedAssets SCM segment, Pamplona and Vizient have agreed to coordinate efforts in select service areas to serve their mutual members and customers.
“Vizient’s acquisition of MedAssets’ SCM and Sg2 businesses creates a stronger, more robust suite of offerings that appeal to leaders and clinicians in the organizations we serve – from academic medical centers, to non-acute and acute care centers, to pediatric facilities,” said Curt Nonomaque, president and chief executive officer of Vizient. “They will benefit from our expanded capabilities in sourcing, consulting, analytics and collaboration to gain insight that fuels care innovation and operational efficiency, and ultimately, improves people’s lives.”
Pamplona purchased MedAssets for $31.35 per share, which represents a total enterprise value of approximately $2.7 billion. The transaction closed in January 2016. Vizient purchased the SCM segment of MedAssets for an undisclosed sum.
For more information, visit www.medassets-precyse.com
About Pamplona Capital Management
Pamplona Capital Management is a London and New York based specialist investment manager established in 2005 that provides an alternative investment platform across private equity, fund of hedge funds and single manager hedge fund investments. Pamplona Capital Management, LLP manages over USD 10 billion in assets across a number of funds for a variety of clients including public pension funds, international wealth managers, multinational corporations, family offices and funds of hedge funds. Pamplona is currently managing its fourth private equity fund, Pamplona Capital Partners IV LP, which was raised in 2014. Pamplona invests long-term capital across the capital structure of its portfolio companies in both public and private market situations. Please visit Pamplonafunds.com for more information.
MedAssets is a healthcare performance improvement company that combines strategic market insight with rapid operational execution to help providers sustainably serve the needs of their communities. More than 4,500 hospitals and 123,000 non-acute healthcare providers rely on our solutions to reduce the total cost of care, enhance operational efficiency, align clinical delivery, and improve revenue performance across the System of CARE. For more information, please visit medassets.com .
Precyse uniquely interweaves people, technology and education to remove barriers between clinical and financial operations, enabling healthcare organizations to thrive. The company has helped nearly 5,000 healthcare organizations nationwide improve efficiency and deliver tangible outcomes for more than fifteen years. Precyse offers fully outsourced Health Information Management (HIM) Services, Medical Coding, Clinical Documentation Improvement (CDI), Medical Transcription, Cancer Registry and Oncology Data Management; an HIM Automation platform with expert workflow technologies and Natural Language Processing (NLP) that supports all inpatient and outpatient Computer Assisted Coding, and Computer Assisted CDI needs; and Precyse University™, an education solution targeted towards helping hospitals optimize coding, revenue cycle management, healthcare operations, clinical documentation, and case management practices before they hit the bottom line. Please visit precyse.com for more information.
About Vizient, Inc.
Vizient, Inc., the largest member-owned health care company in the country, is dedicated to serving members and customers through innovative data-driven solutions, expertise and collaborative opportunities that lead to improved patient outcomes and lower costs. Vizient’s diverse membership and customer base includes academic medical centers, pediatric facilities, community hospitals, integrated health delivery networks and non-acute health care providers, and combined this represents almost $100 billion in annual purchasing volume. The Vizient brand identity represents the integration of VHA Inc., University HealthSystem Consortium and Novation, which combined in 2015, as well as the recently acquired MedAssets’ Spend and Clinical Resource Management (SCM) segment, which includes Sg2. Headquarters are in Irving, Texas, with locations in Chicago and other cities across the United States. Please visit www.vizientinc.com as well as our newsroom , blog , Twitter , LinkedIn and YouTube pages for more information about the company.
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Business Wire
GSMA15.11.2018 09:02 | pressemeddelelse
GSMA Welcomes Germany’s 5G Spectrum Award, but Cautions against Unnecessary Conditions
ENTERSEKT15.11.2018 09:02 | pressemeddelelse
Entersekt Sets Sights on the Nordics
MOBIDIAG15.11.2018 07:32 | pressemeddelelse
Mobidiag Receives Final €4M Tranche of €15M EIB Financing
IPSEN/CABOMETYX15.11.2018 07:32 | pressemeddelelse
European Commission approves Ipsen’s Cabometyx® (cabozantinib) for the treatment of hepatocellular carcinoma in adults previously treated with sorafenib
CHINA-HI-TECH-FAIR15.11.2018 03:02 | pressemeddelelse
Highlights of China’s No. 1 High-Tech Fair CHTF 2018
CA-NEXON-AMERICA-INC14.11.2018 22:02 | pressemeddelelse
MapleStory Prepares for Epic Battle Against the Black Mage in Gathering of Heroes Event
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum